Balyasny Asset Management
MIRM icon

Balyasny Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Balyasny Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$23.3M Buy
2025
Q2 		– Sell
2025
Q1 		$1.21M Buy
2024
Q4 		$775K Buy
2024
Q2 		– Sell
2024
Q1 		$252K Buy
2023
Q4 		– Sell
2023
Q3 		$572K Buy
2023
Q2 		– Sell
2023
Q1 		$246K Buy